Table 5 PROGRESS comorbidities
Variable | DrotAA n = 882 | Non-DrotAA n = 11,610 | Total n = 12,492 | P value |
|---|---|---|---|---|
Diabetes, n (%) | (n = 766) 164 (21.4) | (n = 10,352) 2441 (23.6) | (n = 11,118) 2605 (23.4) | 0.17 |
Chronic lung disease, n (%) | (n = 870) 136 (15.6) | (n = 11,447) 1924 (16.8) | (n = 12,317) 2060 (16.7) | 0.37 |
Active cancer, n (%) | (n = 844) 102 (12.1) | (n = 11,101) 1787 (16.1) | (n = 11,945) 1889 (15.8) | 0.002 |
Congestive heart failure, n (%) | (n = 879) 97 (11.0) | (n = 11,460) 1630 (14.2) | (n = 12,339) 1727 (14.0) | 0.009 |
Chronic renal insufficiency, n (%) | (n = 872) 54 (6.2) | (n = 11,481) 1285 (11.2) | (n = 12,353) 1339 (10.8) | <0.001 |
Chronic liver disease, n (%) | (n = 843) 48 (5.7) | (n = 11,142) 727 (6.5) | (n = 11,985) 775 (6.5) | 0.34 |
Other, n (%) | (n = 768) 197 (25.7) | (n = 10,369) 2473 (23.9) | (n = 11,125) 2670 (24.0) | 0.90 |